Insider · CIK 0002111543
Jonathan M Cohen
Files at AIDX (20/20 Biolabs, Inc.). First filing -, latest -.
In brief
Jonathan M Cohen files SEC Form 4 as CEO, director and 10% owner at AIDX (20/20 Biolabs, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jonathan M Cohen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | AIDX 20/20 Biolabs, Inc. | AGrant or award Stock Optionderivative | +352,936 | $0.00 | $0 | 352,936 | Mar 4, 2026 |
Questions about Jonathan M Cohen
Answered from the filings on this page, as of the latest one.
Is Jonathan M Cohen buying or selling?
Jonathan M Cohen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jonathan M Cohen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan M Cohen has 0.
Where does Jonathan M Cohen file Form 4?
Jonathan M Cohen has filed Form 4 at AIDX (20/20 Biolabs, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.